Wordt geladen...

Platinum-Taxol non-cross resistance in epithelial ovarian cancer.

The aim of this study was to assess the clinical evidence for platinum-Taxol non-cross-resistance in patients with epithelial ovarian cancer. Unlike other studies, only patients who had demonstrably progressive disease on platinum therapy were analysed. Patients received 135-200 mg m-2 of Taxol over...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Gore, M. E., Preston, N., A'Hern, R. P., Hill, C., Mitchell, P., Chang, J., Nicolson, M.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Nature Publishing Group 1995
Onderwerpen:
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2033816/
https://ncbi.nlm.nih.gov/pubmed/7779729
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!